Biomedical‐Optical‐Window Tailored Cyanines for Steerable Inflammatory Bowel Disease Theranostic

Abstract

Tailored photophysical properties and chemical activity is the ultimate pursuit of functional dyes for in vivo biomedical theranostics. In this work, the independent regulation of the absorption and fluorescence emission wavelengths of heptamethine cyanines is reported. These dyes retain near‐infrared fluorescence emission (except a nitro‐modified dye) while feature variable absorption wavelengths ranging from 590 to 860 nm. This enables to obtain customized functional dyes that meet the excitation and fluorescence wavelength requirements defined by the optical properties of tissues for in vivo biomedical applications. Typically, a nitro‐modified photothermal active derivative Cy‐Mu‐7‐9 is used, which features strong absorption at 810 nm in PBS, a wavelength that balanced the tissue penetration depth and non‐specific photothermal effect, to realize non‐destructive inflammatory bowel disease (IBD) therapy via photothermal induced up‐regulation of heat shock protein 70 in the intestinal epithelial cells. The corresponding amino‐modified dye Cy‐Mu‐7‐9‐NH2, which can be formed in health enteric cavity by Cy‐Mu‐7‐9 after oral administration, is a fluorescence compound with the emission of 800 nm in PBS. Based on the IBD sensitive transformation of Cy‐Mu‐7‐9 and Cy‐Mu‐7‐9‐NH2, in vivo IBD theranostic and therapeutic effect evaluation is realized via the synergy of fluorescence imaging and photothermal therapy for the first time.